Financials
- Market Capitalization 11.33 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
40.64
売上高対価格比率
3.42
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 816 | AXSM Axsome Therapeutics, Inc. - Common Stock | 235.26 USD | +3.06% | -5.65% | -7.75% | +80.69% | 12.11 B USD | ||
| 823 | SMMT Summit Therapeutics Inc. - Common Stock | 15.47 USD | +1.11% | -1.78% | +9.56% | -22.10% | 12.01 B USD | ||
| 856 | TECH Bio-Techne Corp - Common Stock | 71.23 USD | -0.18% | +0.82% | +26.27% | +37.03% | 11.15 B USD | ||
| 879 | ABVX Abivax SA - American Depositary Shares | 134.91 USD | -0.79% | -4.19% | +36.27% | +1246.41% | 10.60 B USD |